Literature DB >> 31222471

Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.

Muhammad Hasan1, Dharmesh Patel1, Natalie Ellis2, Steven P Brown2, Józef R Lewandowski1, Ann M Dixon3.   

Abstract

The activation mechanism of the ErbB family of receptors is of considerable medical interest as they are linked to a number of human cancers, including an aggressive form of breast cancer. In the rat analogue of the human ErbB2 receptor, referred to as Neu, a point mutation in the transmembrane domain (V664E) has been shown to trigger oncogenic transformation. While the structural impact of this mutation has been widely studied in the past to yield models for the active state of the Neu receptor, little is known about the impact of cholesterol on its structure. Given previous reports of the influence of cholesterol on other receptor tyrosine kinases (RTKs), as well as the modulation of lipid composition in cancer cells, we wished to investigate how cholesterol content impacts the structure of the Neu transmembrane domain. We utilized high-resolution magic angle spinning solid-state NMR to measure 13C-13C coupling of selectively labelled probe residues in the Neu transmembrane domain in lipid bilayers containing cholesterol. We observe inter-helical coupling between residues that support helix-helix interactions on both dimerization motifs reported in the literature (A661-XXX-G665 and I659-XXX-V663). We further explore how changes in cholesterol concentration alter transmembrane domain interactions and the properties and mechanics of the bilayer. We interpret our results in light of previous studies relating RTK activity to cholesterol enrichment and/or depletion, and propose a novel model to explain our data that includes the recognition and binding of cholesterol by the Neu transmembrane domain through a putative cholesterol-recognition/interaction amino acid consensus sequence.

Entities:  

Keywords:  Cholesterol-recognition; Membrane bilayers; Neu oncogene; Receptor tyrosine kinase; Solid-state NMR

Mesh:

Substances:

Year:  2019        PMID: 31222471     DOI: 10.1007/s00232-019-00075-4

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  80 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Identification of cholesterol binding sites in the serotonin1A receptor.

Authors:  Durba Sengupta; Amitabha Chattopadhyay
Journal:  J Phys Chem B       Date:  2012-10-24       Impact factor: 2.991

3.  Effects of the oncogenic V(664)E mutation on membrane insertion, structure, and sequence-dependent interactions of the Neu transmembrane domain in micelles and model membranes: an integrated biophysical and simulation study.

Authors:  Andrew J Beevers; Anthony Nash; Martha Salazar-Cancino; David J Scott; Rebecca Notman; Ann M Dixon
Journal:  Biochemistry       Date:  2012-03-14       Impact factor: 3.162

Review 4.  Biophysics in cancer: The relevance of drug-membrane interaction studies.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Cláudia Nunes; Salette Reis
Journal:  Biochim Biophys Acta       Date:  2016-06-29

5.  Solid-state magic-angle spinning NMR of outer-membrane protein G from Escherichia coli.

Authors:  Matthias Hiller; Ludwig Krabben; Kutti R Vinothkumar; Federica Castellani; Barth-Jan van Rossum; Werner Kühlbrandt; Hartmut Oschkinat
Journal:  Chembiochem       Date:  2005-09       Impact factor: 3.164

Review 6.  Membrane fluidity in malignancy. Adversative and recuperative.

Authors:  M Shinitzky
Journal:  Biochim Biophys Acta       Date:  1984

Review 7.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

8.  All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.

Authors:  Rong-Hua Tao; Ichi N Maruyama
Journal:  J Cell Sci       Date:  2008-09-09       Impact factor: 5.285

9.  Dimerization of Neu/Erb2 transmembrane domain is controlled by membrane curvature.

Authors:  Lucie Khemtémourian; Sébastien Buchoux; Fabien Aussenac; Erick J Dufourc
Journal:  Eur Biophys J       Date:  2006-11-08       Impact factor: 2.095

10.  The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy.

Authors:  Zahi Mitri; Tina Constantine; Ruth O'Regan
Journal:  Chemother Res Pract       Date:  2012-12-20
View more
  4 in total

Review 1.  Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.

Authors:  Justin M Westerfield; Francisco N Barrera
Journal:  J Biol Chem       Date:  2019-12-25       Impact factor: 5.157

2.  Special Issue: Membrane and Receptor Dynamics.

Authors:  Shikha Prakash; Durba Sengupta
Journal:  J Membr Biol       Date:  2019-10       Impact factor: 1.843

3.  Role of Cholesterol in Transmembrane Dimerization of the ErbB2 Growth Factor Receptor.

Authors:  Aiswarya B Pawar; Durba Sengupta
Journal:  J Membr Biol       Date:  2021-01-28       Impact factor: 1.843

Review 4.  It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases.

Authors:  Tamas Kovacs; Florina Zakany; Peter Nagy
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.